Agence de Médecine Préventive, s/c Institut Pasteur, 25-28 rue du Docteur Roux, 75724 Paris Cedex 15, France.
Vaccine. 2012 Mar 28;30(15):2588-93. doi: 10.1016/j.vaccine.2012.01.066. Epub 2012 Feb 11.
In January 2010, Côte d'Ivoire became the first GAVI-eligible country in sub-Saharan Africa to establish a National Immunization Technical Advisory Group (NITAG). The Côte d'Ivoire "National Committee of Independent Experts for Vaccination and Vaccines" (CNEIV-CI) was created to strengthen national capacity for evidence-based policy decisions with regard to immunization and vaccines. The primary reasons for success in Côte d'Ivoire were a strong political will, the availability of sufficient national expertise, a step-by-step country-driven process, and the provision of technical assistance to the Ministry of Health. The challenges included operating within the socio-political crisis, and initial reluctance from some stakeholders due to the potential overlap with other existing committees. The latter rapidly dissolved over the course of numerous meetings held with the SIVAC Initiative to clarify the mandate of a NITAG.
2010 年 1 月，科特迪瓦成为撒哈拉以南非洲第一个有资格获得全球疫苗免疫联盟（GAVI）支持的国家，建立了国家免疫技术咨询小组（NITAG）。科特迪瓦“疫苗接种和疫苗独立专家国家委员会”（CNEIV-CI）的成立是为了加强国家在免疫和疫苗方面进行循证政策决策的能力。科特迪瓦取得成功的主要原因是：强烈的政治意愿、具备充足的国家专门知识、分阶段的国家主导进程，以及向卫生部提供技术援助。面临的挑战包括在社会政治危机中运作，以及一些利益攸关方最初因潜在的与其他现有委员会重叠而不愿参与。随着与 SIVAC 倡议举行的多次会议阐明 NITAG 的任务，后者很快就解散了。
